v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jul. 05, 2026
Jun. 29, 2025
Operating activities:    
Net income $ 92,538 $ 96,185
Loss from discontinued operations, net of income taxes 1,836 706
Income from continuing operations 94,374 96,891
Adjustments to reconcile net income from continuing operations to net cash provided by continuing operations:    
Restructuring and other costs 46,183 14,442
Depreciation and amortization 207,095 200,200
Gain on disposition of businesses and assets, net (5,074) 0
Stock-based compensation 19,446 17,864
Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) 1,527 (166)
Amortization of deferred debt financing costs and accretion of discounts 2,440 2,320
Change in fair value of financial securities 9,455 (1,118)
Unrealized Foreign Exchange (Gain) Loss Related to Proceed from Sale of Business 186 140
Changes in operating assets and liabilities which provided (used) cash, excluding effects from companies purchased and divested:    
Accounts receivable, net 43,916 (21,901)
Inventories (4,778) 5,642
Accounts payable (18,064) 3,278
Increase (Decrease) in Accrued Expenses and Other (78,876) (49,177)
Net cash provided by operating activities of continuing operations 317,830 268,415
Net cash used in operating activities of discontinued operations (10,657) (5,942)
Net cash provided by operating activities 307,173 262,473
Investing activities:    
Capital expenditures (30,848) (34,850)
Purchases of investments and notes receivables (3,561) 0
Proceeds from investments and notes receivables 7,496 0
Proceeds from disposition of property, plant and equipment 12,039 0
Proceeds from disposition of businesses and assets 158 229
Cash paid for acquisitions, net of cash acquired (67,061) 0
Net cash used in investing activities of continuing operations (81,777) (34,621)
Net cash provided by investing activities of discontinued operations 0 18,750
Net cash used in investing activities (81,777) (15,871)
Financing activities:    
Payments of debt financing issuance costs 0 (2,474)
Payments of other credit facilities 0 (103)
Payment for Contingent Consideration Liability, Financing Activities (350) (1,978)
Proceeds from issuance of common stock under stock plans 6,437 2,632
Purchases of common stock (102,488) (447,501)
Dividends paid (15,654) (16,715)
Net cash used in financing activities (112,055) (466,139)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (10,190) 48,075
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalent 103,151 (171,462)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at beginning of period 921,030 1,164,452
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at end of period 1,024,181 992,990
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]    
Cash and cash equivalents 1,022,943 991,849
Restricted Cash, Current 713 1,141
Restricted Cash, Noncurrent 525 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 1,024,181 $ 992,990